TP53 and papilloma: As for the most malignant muscle-invasive tumors (MIBCs), the mutations of TP53 were more frequent in MIBC when compared with non-muscle-invasive tumor (NMIBCs) and benign papilloma (Fig. 1e, Fisher’s exact test, p = 0.035).